{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-24-016977","form_type":"8-K","ticker":"ANGO","cik":"0001275187","company_name":"ANGIODYNAMICS INC","filed_at":"2024-04-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.678483+00:00","generated_at":"2026-06-04T04:23:09.268941+00:00","sec_items":["1.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"AngioDynamics settles patent litigation with BD; $7M upfront, $2.5M annual minimums","bullets":["One-time payment of $7M to BD, with $3M due within 5 business days and remainder over 12 months.","Minimum annual payments of $2.5M for six years through Feb 2029; additional payments based on 6% of port product net sales.","Contingent $3M payment due if Federal Circuit reverses invalidity findings in pending appeal (CAFC No. 23-2056).","Cross-licenses granted: BD licenses certain port patents to AngioDynamics; AngioDynamics licenses certain catheter patents.","Mutual covenants not to sue and releases; no admission of misconduct or liability."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-24-016977","json":"https://secwatch.observer/filing/0001140361-24-016977.json","markdown":"https://secwatch.observer/filing/0001140361-24-016977.md","text":"https://secwatch.observer/filing/0001140361-24-016977.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1275187/000114036124016977/0001140361-24-016977-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1275187/000114036124016977/ef20025660_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T04:23:09.268941+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9a2ecb026f6e8054897932abb7f52c00f428d065","claim":"ANGIODYNAMICS INC entered into Settlement Agreement with Becton, Dickinson and Company, C.R. Bard, Inc. and Bard Peripheral Vascular Inc. valued at one-time lump sum payment to BD in the amount of $7 million, $3 million of which will be payable wit (effective 2024-03-31).","evidence_excerpt":"On March 31, 2024, AngioDynamics and BD entered into a Settlement Agreement (the “Settlement Agreement”) to resolve the Actions.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036124016977/0001140361-24-016977-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"settlement"},{"label":"Counterparty","value":"Becton, Dickinson and Company, C.R. Bard, Inc. and Bard Peripheral Vascular Inc."},{"label":"Value","value":"one-time lump sum payment to BD in the amount of $7 million, $3 million of which will be payable wit"},{"label":"Effective","value":"2024-03-31"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}